(3S)-3-Isobutyl-2,5-piperazinedione

Modify Date: 2025-08-25 14:41:49

(3S)-3-Isobutyl-2,5-piperazinedione Structure
(3S)-3-Isobutyl-2,5-piperazinedione structure
Common Name (3S)-3-Isobutyl-2,5-piperazinedione
CAS Number 5845-67-0 Molecular Weight 170.209
Density 1.0±0.1 g/cm3 Boiling Point 442.9±38.0 °C at 760 mmHg
Molecular Formula C8H14N2O2 Melting Point 255ºC
MSDS USA Flash Point 207.4±26.9 °C

 Use of (3S)-3-Isobutyl-2,5-piperazinedione


Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. Cyclo(glycyl-L-leucyl) inhibits the development of Morphine induced pain relief as well as dopamine receptor supersensitivity in rats. Cyclo(glycyl-L-leucyl) has the potential for the prevention of tardive and/or L-DOPA (HY-N0304)-induced dyskinesias[1][2].

 Names

Name cyclo(-leu-gly)
Synonym More Synonyms

 (3S)-3-Isobutyl-2,5-piperazinedione Biological Activity

Description Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. Cyclo(glycyl-L-leucyl) inhibits the development of Morphine induced pain relief as well as dopamine receptor supersensitivity in rats. Cyclo(glycyl-L-leucyl) has the potential for the prevention of tardive and/or L-DOPA (HY-N0304)-induced dyskinesias[1][2].
Related Catalog
Target

Dopamine Receptor

In Vivo Cyclo(glycyl-L-leucyl) (8 mg/kg; 皮下给药) 在阿扑吗啡 (APO) 后 24 小时给予,可减弱由急性高剂量 APO (5 mg/kg; 皮下给药) 引起的 DA 受体超敏反应[1]。 Animal Model: Male Swiss-Webster mice, 20-25g[1] Dosage: 8 mg/kg Administration: SC; single dose given 24h after apomorphine (APO) Result: Attenuated the DA receptor supersensitivity caused by acute high dose APO (5 mg/kg; s.c.).
References

[1]. J Z Fields, et al. The effects of cyclo(leucyl-glycyl) on nigrostriatal dopaminergic supersensitivity--inhibition of apomorphine-induced climbing. Neuropeptides. 1990 Aug;16(4):207-11.  

[2]. H N Bhargava, et al. Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats. Life Sci. 1980 Jul 14;27(2):117-23.  

 Chemical & Physical Properties

Density 1.0±0.1 g/cm3
Boiling Point 442.9±38.0 °C at 760 mmHg
Melting Point 255ºC
Molecular Formula C8H14N2O2
Molecular Weight 170.209
Flash Point 207.4±26.9 °C
Exact Mass 170.105530
PSA 58.20000
LogP -0.66
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.453

 Synonyms

L-Leucylglycine diketopiperazine
MORPHINE TOLERANCE PEPTIDE
(3S)-3-Isobutyl-2,5-piperazinedione
2,5-Piperazinedione, 3-(2-methylpropyl)-, (3S)-
MORPHIN,TOLERANCE PEPTIDE
Cyclo(Leu-Gly)
3-isobutylpiperazine-2,5-quinone
(3S)-3-Isobutylpiperazine-2,5-dione
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here

Get all suppliers and price by the below link:

(3S)-3-Isobutyl-2,5-piperazinedione suppliers


Price: ¥1365/250mg

Reference only. check more (3S)-3-Isobutyl-2,5-piperazinedione price

Related Compounds: More...
L-Leucylglycine diketopiperazine
108315-75-9
(3S)-3-Isobutyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
104874-01-3
(2S,3S)-3-(2,5-difluorophenyl)-2-methyl-4-[1-(1,2,4-triazolyl)]-1,3-butanediol
832152-07-5
Cyclo(Phe-Leu)
3354-31-2
Cyclo(Tyr-Gly)
5625-49-0
Cyclo(Tyr-Leu)
82863-65-8
(S)-1-BENZYL-3-ETHYLPIPERAZINE-2,5-DIONE
325145-36-6
2,5-Piperazinedione, 3-[(4-methylphenyl)methyl]-, (3S)- (9CI)
612502-10-0
2,5-Piperazinedione, 3-[(3-methylphenyl)methyl]-, (3S)- (9CI)
612502-11-1
N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-4,6-dioxa-10-thia-12-azatricyclo[7.3.0.0^{3,7}]dodeca-1(9),2,7,11-tetraen-11-amine
862976-73-6
N-(3-(benzo[d]thiazol-2-yl)-6-methyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]thiazol-6-amine
862976-75-8
N-(4-(benzo[d]thiazol-2-yl)thiazol-2-yl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]thiazol-6-amine
862976-80-5
N-[11-(methylsulfanyl)-3,12-dithia-5,10-diazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),4,7,10-pentaen-4-yl]-4,6-dioxa-10-thia-12-azatricyclo[7.3.0.0^{3,7}]dodeca-1(9),2,7,11-tetraen-11-amine
862976-81-6
N-{11-methyl-3,10-dithia-5,12-diazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),4,7,11-pentaen-4-yl}-10,13-dioxa-4-thia-6-azatricyclo[7.4.0.0^{3,7}]trideca-1,3(7),5,8-tetraen-5-amine
862976-97-4
N-(benzo[d]thiazol-2-yl)-2-((2,6,8-trimethyl-5,7-dioxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)acetamide
852168-48-0
2-((2-ethyl-6,8-dimethyl-5,7-dioxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)-N-(naphthalen-1-yl)acetamide
852169-36-9
N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-((2-ethyl-6,8-dimethyl-5,7-dioxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)acetamide
852169-92-7
N-(2-chloro-5-(trifluoromethyl)phenyl)-2-((2-ethyl-6,8-dimethyl-5,7-dioxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)acetamide
852169-98-3
2-((2-ethyl-6,8-dimethyl-5,7-dioxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)-N-(4-nitrophenyl)acetamide
852170-02-6